Fezolinetant
CAS: 1629229-37-3
Ref. 3D-EQC22937
| 2mg | 172.00 € | ||
| 5mg | 248.00 € | ||
| 10mg | 364.00 € | ||
| 25mg | 518.00 € | ||
| 50mg | 801.00 € |
Product Information
Fezolinetant is a drug for the treatment of menopausal symptoms. It is designed to be administered as a single dose, with the primary analysis being a questionnaire on the frequency and severity of symptoms. Fezolinetant has been shown to be efficacious in treating autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Fezolinetant also prevents cancer in mice by inhibiting the invasion and migration of tumor cells. The drug binds to receptors in cells that are involved in cancer cell growth and proliferation, which blocks the production of proteins that are essential for tumor cell division. This drug also has an efficient method of delivery, which may reduce side effects.
Chemical properties
Technical inquiry about: 3D-EQC22937 Fezolinetant
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
